Longtime New York resident Roger Coleman is the Chief Strategy Office at Disaster Technologies where he helps the company navigate deal sourcing. Recently the company announced a new board member has been added in Nivi Achanta.
Longtime New York resident Roger Coleman is the Chief Strategy Office at Disaster Technologies where he helps the company navigate deal sourcing. Recently the company announced a new board member has been added in Nivi Achanta.
Achanta is currently the CEO and founder of Soapbox Project, a startup that helps busy millennials fight climate change straight from their inbox. Soapbox gives its users bite-sized, informative action plans for social and environmental issues they care about.
To learn more about the recent addition of Achanta, go to https://blog.disastertech.com/the-latest/disaster-tech-names-nivi-achanta-as-new-board-member
As the Chief Strategy Officer for Disaster Technologies, longtime New York resident Roger Coleman is involved with a number of high profile responsibilities for the company.
In early October, Disaster Tech announced the availability of Data science Integrated Collaboration Environment (DICE) in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. Disaster Tech customers can now take advantage of the productive and trusted Azure cloud platform, with streamlined deployment and management.
The platform uses analytics to better forecast disasters and therefore, allows for another level of preparedness. All in all, DICE is using real-time data for situational awareness and operational coordination across multiple hazards such as wildfires, hurricanes, and COVID-19 – all on Microsoft Teams. This availability on Teams has accelerated Disaster Tech’s ability to arm disaster managers with the tools they need to perform in high-stress situations.
Roger Coleman, along with CEO Sean Griffin are excited about the potential in allowing disaster managers the ability to perform in high stress situations.
“The availability of DICE in the Microsoft Azure Marketplace and Microsoft Teams reveals Disaster Tech’s commitment to delivering a collaborative and sophisticated environment for disaster and emergency teams,” said Sean Griffin, Chief Executive Officer and Founder of Disaster Tech. “We know customers are looking for solutions to accurately — and simply — integrate their own unique data to accelerate decision making processes before and when disasters hit. This integration helps us deliver a single pane of glass platform to multiple high-risk sectors, including government, utility and the healthcare industry, resulting in increased data visualization, streamlined report generation, and significant savings to lives, money and time.”
To learn more about Disaster Tech and the latest news, go to: https://www.disastertech.com/
To learn more about Roger Coleman, check him out on LinkedIn: https://www.linkedin.com/in/roger-coleman/
Hurricane Dorian reached the devastating level of category five on September 1, 2019. The storm then hit the Abaco Islands in the Bahamas as well as Grand Bahama Island. It later restrengthened, impacting the Outer Banks in North Carolina. With over 185-mile-per-hour winds, Dorian recorded the highest sustained winds of an Atlantic Ocean-based hurricane since the Labor Day Hurricane of 1935. Damage caused by the disaster totaled around $2 billion.
New York resident and investor, Roger Coleman, owns Coleman Ventures & Coleman Group Partners-based in New York City. As proprietor, Roger Coleman is involved in impacting investing, committing some of the company's returns to his charitable foundation for positive outcomes around the world.
In September 2020, Mr. Coleman helped facilitate a deal between Santen Pharmaceutical Company, Ltd. (Santen) and Eyevance Holdings, LLC (Eyevance) that culminated in the former purchasing all outstanding shares of the latter. Santen is an ophthalmological company specializing in pharmaceuticals and medical devices. Eyevance makes topical products for the eyes.
Currently, Santen is the market leader in Japan and patients in 60 other countries use its products. This purchase will allow the company to establish a larger business base in the US while offering patients more value. By gaining access to the US market, they hope to facilitate corporate growth and the ability to contribute to making ophthalmic treatments worldwide.